Template:Percutaneous Coronary Intervention

Revision as of 15:55, 18 October 2012 by Shankar Kumar (talk | contribs)
Jump to navigation Jump to search

Percutaneous Coronary Intervention Microchapters

Home

Patient Info

Guideline Recommendations

CAD Revascularization:

Heart Team Approach to Revascularization Decisions
Left Main Coronary Artery Disease
Non-Left Main Coronary Artery Disease
Revascularization to Improve Symptoms
Dual Antiplatelet Therapy Compliance and Stent Thrombosis
Hybrid Coronary Revascularization

Pre-procedural Considerations:

Radiation Safety
Contrast-Induced Acute Kidney Injury
Anaphylactoid Reactions
Statin Treatment
Bleeding Risk
Role of Onsite Surgical Backup

Procedural Considerations:

Vascular Access
PCI in Specific Clinical Situations:
PCI in patients with Asymptomatic Ischemia or CCS Class I or II Angina
PCI in patients with CCS Class III Angina
PCI in patients with Unstable Angina/Non–ST-Elevation Myocardial Infarction
PCI in patients with ST-Elevation Myocardial Infarction:
Coronary Angiography Strategies in STEMI
Primary PCI of the Infarct Artery
Delayed or Elective PCI in patients with STEMI
STEMI: General and Specific Considerations
PCI in Fibrinolytic-Ineligible Patients
Facilitated PCI
Rescue PCI
PCI After Successful Fibrinolysis or for Patients Not Undergoing Primary Reperfusion
PCI in patients with Cardiogenic Shock
PCI in patients with Prior Coronary Bypass Surgery
Revascularization Before Non-cardiac Surgery
Coronary Stents
Adjunctive Diagnostic Devices:
Fractional Flow Reserve
Intravascular Ultrasound
Adjunctive Therapeutic Devices:
Coronary Atherectomy
Thrombectomy
Laser Angioplasty
Cutting Balloon Angioplasty
Embolic Protection Devices
Percutaneous Hemodynamic Support Devices
Antiplatelet therapy:
Oral Antiplatelet Therapy
Intravenous Antiplatelet therapy:
STEMI
UA/NSTEMI
SIHD
Anticoagulant Therapy:
Parenteral Anticoagulants During PCI
Unfractionated Heparin
Enoxaparin
Bivalirudin and Argatroban
Fondaparinux
No-Reflow Pharmacological Therapies
PCI in Specific Anatomic Situations:
Chronic Total Occlusions
Saphenous Vein Grafts
Bifurcation Lesions
Aorto-Ostial Stenoses
Calcified Lesions
PCI in Specific Patient Populations:
Chronic Kidney Disease
Peri-procedural Myocardial Infarction Assessment
Vascular Closure Devices

Post-Procedural Considerations:

Post-procedural Antiplatelet Therapy:
Proton Pump Inhibitors and Antiplatelet Therapy
Clopidogrel Genetic Testing
Platelet Function Testing
Restenosis:
Exercise Testing
Cardiac Rehabilitation

Post-Procedural Considerations:

Quality and Performance
Certification and Maintenance of Certification
Certification and Maintenance of Certification

Percutaneous Coronary Intervention On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Percutaneous Coronary Intervention

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Percutaneous Coronary Intervention

CDC on Percutaneous Coronary Intervention

Percutaneous Coronary Intervention in the news

Blogs on Percutaneous Coronary Intervention

Directions to Hospitals Treating Percutaneous Coronary Intervention

Risk calculators and risk factors for Percutaneous Coronary Intervention